These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 9374133

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins.
    Tornoci L, Scheraldi CA, Li X, Ide H, Goldberg IJ, Le NA.
    J Lipid Res; 1993 Oct; 34(10):1793-803. PubMed ID: 8245727
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C, Tremblay M, Fredenrich A, Davignon J, Cohn JS.
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Demonstration of apolipoprotein CII in guinea pigs. Functional characteristics, cDNA sequence, and tissue expression.
    Andersson Y, Thelander L, Bengtsson-Olivecrona G.
    J Biol Chem; 1991 Mar 05; 266(7):4074-80. PubMed ID: 1999402
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Isolation and characterization of recombinant human apolipoprotein C-II expressed in Escherichia coli.
    Wang CS, Downs D, Dashti A, Jackson KW.
    Biochim Biophys Acta; 1996 Aug 16; 1302(3):224-30. PubMed ID: 8765143
    [Abstract] [Full Text] [Related]

  • 12. Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions.
    Fredenrich A, Giroux LM, Tremblay M, Krimbou L, Davignon J, Cohn JS.
    J Lipid Res; 1997 Jul 16; 38(7):1421-32. PubMed ID: 9254067
    [Abstract] [Full Text] [Related]

  • 13. Characterization of the lipid-binding properties and lipoprotein lipase inhibition of a novel apolipoprotein C-III variant Ala23Thr.
    Liu H, Labeur C, Xu CF, Ferrell R, Lins L, Brasseur R, Rosseneu M, Weiss KM, Humphries SE, Talmud PJ.
    J Lipid Res; 2000 Nov 16; 41(11):1760-71. PubMed ID: 11060345
    [Abstract] [Full Text] [Related]

  • 14. Apolipoprotein C-II modifications associated with an infusion of artificial lipid particles.
    Iriyama K, Nishiwaki H, Terashima H, Tonouchi H, Miki C, Suzuki H, Carpentier YA.
    JPEN J Parenter Enteral Nutr; 1988 Nov 16; 12(1):60-2. PubMed ID: 3125357
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fate of apolipoproteins C-1, C-iii, and E during lipolysis of human very low density lipoproteins in vitro.
    Tam SP, Dory L, Rubinstein D.
    J Lipid Res; 1981 May 16; 22(4):641-51. PubMed ID: 7276737
    [Abstract] [Full Text] [Related]

  • 18. Characterization of recombinant wild type and site-directed mutations of apolipoprotein C-III: lipid binding, displacement of ApoE, and inhibition of lipoprotein lipase.
    Liu H, Talmud PJ, Lins L, Brasseur R, Olivecrona G, Peelman F, Vandekerckhove J, Rosseneu M, Labeur C.
    Biochemistry; 2000 Aug 08; 39(31):9201-12. PubMed ID: 10924113
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.